Home › Calculator › PGEN Dividend Calculator 2026
PGEN Dividend DRIP Calculator 2026
30.82% YieldHealthcarePrecigen, Inc. · NASDAQ
Price: $6.49 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PGEN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your PGEN snowball 📈
$10,000 in PGEN → $26476024.89M in 10 years · $2,199,365,737,570.55/month
About Precigen, Inc. (PGEN) — Dividend Analysis 2026
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.
Compare PGEN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PGEN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PGEN position with:
🌍 PGEN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PGEN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 30.82% | 28.02% | $3,082 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 26.20% | 23.40% | $2,620 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 24.66% | 21.86% | $2,466 / yr |
| 🇬🇧 UK ISA | 0% | 30.82% | 28.02% | $3,082 / yr |
| 🇬🇧 UK Taxable | 8.75% | 28.12% | 25.32% | $2,812 / yr |
| 🇨🇦 TFSA | 0% | 30.82% | 28.02% | $3,082 / yr |
| 🇨🇦 CA Taxable | 25% | 23.12% | 20.32% | $2,312 / yr |
| 🇦🇺 Super (pension) | 15% | 26.20% | 23.40% | $2,620 / yr |
| 🇦🇺 AU Taxable | 30% | 21.57% | 18.77% | $2,157 / yr |
| 🇩🇪 DE Taxable | 26.375% | 22.69% | 19.89% | $2,269 / yr |
| 🇫🇷 FR Taxable | 30% | 21.57% | 18.77% | $2,157 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PGEN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PGEN Dividend Payment Schedule
PGEN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 PGEN vs Healthcare Benchmarks
How PGEN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PGEN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PGEN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-08-26 | 185,000 | $7.44 | $1.38M | ||
| Buy | 2026-08-21 | 3,411 | $7.23 | $24.7K | ||
| M-Exempt | 2026-08-23 | 5,208 | — | — | ||
| F-InKind | 2026-08-23 | 2,488 | $7.20 | $17.9K | ||
| M-Exempt | 2026-08-23 | 5,208 | — | — | ||
| M-Exempt | 2026-08-23 | 7,291 | — | — | ||
| F-InKind | 2026-08-23 | 3,577 | $7.20 | $25.8K | ||
| M-Exempt | 2026-08-23 | 7,291 | — | — | ||
| M-Exempt | 2026-08-21 | 34,658 | $2.33 | $80.8K | ||
| M-Exempt | 2026-08-25 | 15,342 | $2.33 | $35.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where PGEN earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PGEN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Precigen, Inc. (PGEN) is currently trading at $6.49, 41% below its 52-week high. The current dividend yield is 30.82% based on an annual payout of $2.00 per share.
PGEN (Precigen, Inc.) — 30.82% Dividend Yield Analysis
Precigen, Inc. (PGEN) is a healthcare stock currently trading at $6.49 with a dividend yield of 30.82%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (30.82%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.